Human papillomavirus infection in the female population of Antwerp, Belgium: prevalence in healthy women, women with premalignant lesions and cervical cancer

Worldwide there is a strong relation between the presence of human papillomavirus (HPV) and the development of cervical cancer. This study investigated the prevalence and genotype of HPV in women with normal smears, women with premalignant lesions and women with cervical cancer in Antwerp, Belgium. Type-specific polymerase chain reaction (PCR) for HPV types 16 and 18 and general primer PCR (GP5+/6+) was performed on DNA extracted from paraffin-embedded tissue from women with lesions or fresh material from controls. HPV was detected in 11% of controls, 61% of women with atypia, 77% of women with CIN lesions and 88% of women with cervical carcinoma (chi2 trend, 273, p<0.001). The odds ratio for high-risk HPV types was 9.3 for atypia (95%CI. 4.3-19.8), 33.6 for CIN lesions (95%CI, 19.3-58.6) and 78.8 for cervical cancer (95%CI, 39.2-158.3). In total, 19 different HPV genotypes were detected, including five low risk HPV types. Seven of the 14 high-risk HPV types were detected in cervical cancer patients. Based on our study it is suggested that a prophylactic vaccine based on a cocktail of a limited number of high-risk HPV types should be considered in order to protect most women from developing cervical cancer.

Cervical cancer, human papillomavirus, prevalence, PCR

[1] Parkin D. M., Pisani P., F erlay J.: "Estimates of the worldwide incidence of eighteen m ajor cancers in 1985". Int. J. Cancer, 1993, 54, 594.

[2] Zur Hausen H.: "Condylomata acuminata and human genital cancer". Cancer Res., 1976, 794.

[3] Kjaer S. K., van den Brule A. J., Bock J. E., Poll A., Engholm G., Sherman M. E. et al.: "Human papillomavirus - the most significant risk determinant of cervical intraepithelial neoplasia". Int. J Cancer, 1996, 65, 601.

[4] Bosch F. X., Manos M. M., Munoz N., Sherman M., Jansen A. M., Peto J. et al.: "Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group". J. Natl. Cancer Inst., 1995, 87, 796.

[5] Walboomers J. M. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J. A., Shah K. V. et al.: "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide". J. Pathol., 1999, 189, 12.

[6] Wright D. K., Manos M. M.: "Sample preparation from paraffin embedded tissues". In: PCR Protocols: A Guide to Methods and Applications. Innes M. A., Gelfand D. H., Sninsky J. J., eds. San Diego: Academic Press, 1990: 153.

[7] Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T. et al.: "Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase". Science , 1988, 239, 487.

[8] Baay M. F. D., Quint W. G. V., Koudstaal J., Hollema H., Duk J. M., Burger M. P. M. et al.: "Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas". J. Clin Microbial., 1996, 34, 745.

[9] de Roda Husman A. M., Walboomers J.M., van den Brule A. J., Meijer C. J., Snijders P. J.: "The use of general primers GP5 and GP6 elongated at their 3'ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR". J Gen. Viral., 1995, 76, 1057.

[10] van den Brule A. J., Meijer C. J., Bakels Y., Kenemans P., Walboomers J. M.: "Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-spe cific polymerase chain reaction". J. Clin. Microbiol., 1990, 28, 2739.

[11] Vandenvelde C., Scheen R., Yan Pachterbeke C., Loriaux C., Decelle J., Hubert T. et al.: "Prevalence of high risk genital papillomavirus in the Belgian female population determined by fast multiplex polymerase chain reaction". J. Med. Virol., 1992, 36, 279.

[12] Vandenvelde C., Van Beers D.: "High-risk genital papillomaviruses and degree of dysplastic changes in the cervix: a prospective study by fast multiplex polymerase chain reaction in Belgium". J Med. Virol., 1993, 39, 273.

[13] de Roda Husman A. M., Walboomers J.M., Hopman E., Bieker O P., Helmerhorst T. M., Rozendaal L. et al.: "HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related pattern". J. Med. Virol., 1995, 46, 97.

[14] Hagmar B., Kalantari M., Skyldberg B., Moberger B., Johansson B., Walaas L. et al.: "Human papillomavirus in cell samples from Stockholm gynecologic health screening". Act a Cytol., 1995, 39, 741.

[15] Ho G. Y. F., Palan P. R., Basu J., Romney S. L., Kadish A. S., Mikhail M. et al.: "Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia". Int. J. Cancer., 1998, 78, 594.

[16] Van Hal JG., Putzeys T., Pszeniczko J., Weyler J.: "Overscreenmg for cervical cancer in Flanders (Belgium)". Eur. J. Gen. Pract., 1998, 4, 100.

[17] Kruger Kjaer S., van den Brule A. J., Svare E. I., Engholm G., Sherman M. E., Poll P. A. et al.: "Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women". Int. J Cancer, 1998, 76, 613.

[18] Manos M. M., Kinney W. K., Hurley L. B., Sherman M. E., Shieh Ngai J., Kurman R. J. et al.: "Identifying women with cervical neoplasia - using human papillomavirus DNA testing for equivocal Papanicolaou results". JAMA, 1999, 281, 1605.

[19] Nindl I., Lotz B.. Kuhne Heid R., Endisch U., Schneider A.: "Distribution of 14 high risk HPV types in cervical intraepithelial neoplasia detected by a non-radioactive general primer PCR mediated enzyme immunoassay". J. Clin. Pathol., 1999, 52, 17.

[20] Chaouki N., Bosch F. X., Munoz N., Meijer C. J., El Gueddari B., El Ghazi A. et al.: "The viral origin of cervical cancer in Rabat, Morocco". Int. J. Cancer, 1998, 75, 546.

[21] Chichareon S., Herrero R., Munoz N., Bosch F. X., Jacobs M. V., Deacon J. et al.: "Risk factors for cervical cancer in Thailand: a case-control study". J. Natl. Cancer Inst., 1998, 90, 50.

[22] Ngelangel C., Munoz N., Bosch F. X., Limson G. M., Festin M R., Deacon J. et al.: "Causes of cervical cancer in the Philippines: a case-control study". J. Natl. Cancer Inst., 1998, 90, 43.

[23] Burger M. P. M., Hollema H., Pieters W. J. L. M., Quint W. G. V: "Predictive value of human papillomavirus type for histological diagnosis of women with cervical cytological abnormalities". Br. Med. J., 1995, 310, 94.

[24] Matsukura T., Sugase M.: "Identification of genital human papillomaviruses in cervical biopsy specimens: Segregation of specific virus types in specific clinicopathologic lesions". Int. J. Cancer, 1995, 61, 13.